Zafer Tokatli
Research Subjects
Zafer Tokatli has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Muhammed Arif Ibis
Department of Urology King's College Hospital NHS Foundation Trust London UK
5 shared publications - Cihat Özcan
Department of Urology, Gülhane Training and Research Hospital, Ankara, Turkiye
2 shared publications Ferec Efendioğlu
Department of Urology, Gulhane Training and Research Hospital, Ankara, Turkey
2 shared publications- Kemal Sarica
Department of Urology, Hamidiye Faculty of Medicine, University of Health Sciences, 34668 Istanbul, Turkey
2 shared publications - Önder Yaman
Department of Urology Ankara University School of Medicine Ankara Turkey
2 shared publications - Ahmet Barış Aydın
Department of Urology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
1 shared publication
Latest Publications
- 30 September 2026
- Published by Endouroloji Dernegi in Endouroloji Bulteni
- Vol. 18 (3) , 212-220
Comparative Analysis of Avicenna Roboflex® and Conventional Ureteroscopy: A Porcine Model Study of Safety and Feasibility in Stone Management
Objective: Robotic-assisted ureteroscopy is increasingly adopted in endourology. We aimed to evaluate the feasibility and safety of the Avicenna Roboflex® Urology system (Elmed, Ankara, Turkey) compared with conventional ureteroscopy in a porcine model.Materials and Methods: The Avicenna Roboflex® platform was compared with conventional ureteroscopy in a live porcine model (n = 6) in the supine lithotomy position. Two experienced endourologists assessed task performance using Likert scales (1–4) for accuracy/workaround and ease of completion. Intraoperative events and ureteral injury were evaluated using the post-ureteroscopic lesion scale (PULS, 0–5). Histopathological assessment of tissue samples was performed by a blinded pathologist. Paired comparisons were performed using the 2-sided Wilcoxon signed-rank test, with p < 0.05 considered statistically significant.Results: A total of 12 ureteroscopic procedures (6 conventional, 6 robotic) were completed without intraoperative complications. Histopathological analysis revealed no significant differences between groups, with minimal epithelial loss observed only in the proximal ureter. Task performance scores were comparable between groups; however, the robotic system showed a trend toward improved ease in flexible ureteroscope insertion and simulated stone removal. PULS scores were low and similar in both groups.Conclusion: The Avicenna Roboflex® system demonstrated procedural feasibility and an acute tissue safety profile comparable to conventional ureteroscopy in this porcine model. Given the exploratory nature and small sample size of the study, these findings should be considered preliminary and require validation in adequately powered studies.
- 30 September 2026
- Published by Endouroloji Dernegi in Endouroloji Bulteni
- Vol. 18 (3) , 212-220
Comparative Analysis of Avicenna Roboflex® and Conventional Ureteroscopy: A Porcine Model Study of Safety and Feasibility in Stone Management
Objective: Robotic-assisted ureteroscopy is increasingly adopted in endourology. We aimed to evaluate the feasibility and safety of the Avicenna Roboflex® Urology system (Elmed, Ankara, Turkey) compared with conventional ureteroscopy in a porcine model.Materials and Methods: The Avicenna Roboflex® platform was compared with conventional ureteroscopy in a live porcine model (n = 6) in the supine lithotomy position. Two experienced endourologists assessed task performance using Likert scales (1–4) for accuracy/workaround and ease of completion. Intraoperative events and ureteral injury were evaluated using the post-ureteroscopic lesion scale (PULS, 0–5). Histopathological assessment of tissue samples was performed by a blinded pathologist. Paired comparisons were performed using the 2-sided Wilcoxon signed-rank test, with p < 0.05 considered statistically significant.Results: A total of 12 ureteroscopic procedures (6 conventional, 6 robotic) were completed without intraoperative complications. Histopathological analysis revealed no significant differences between groups, with minimal epithelial loss observed only in the proximal ureter. Task performance scores were comparable between groups; however, the robotic system showed a trend toward improved ease in flexible ureteroscope insertion and simulated stone removal. PULS scores were low and similar in both groups.Conclusion: The Avicenna Roboflex® system demonstrated procedural feasibility and an acute tissue safety profile comparable to conventional ureteroscopy in this porcine model. Given the exploratory nature and small sample size of the study, these findings should be considered preliminary and require validation in adequately powered studies.
- Open Access
- 17 April 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (16) , e48099
Predictive factors for the development of urethral stricture in patients undergoing holmium laser enucleation of the prostate: A retrospective study
This study aimed to determine the incidence and predictors of urethral stricture after holmium laser enucleation of the prostate (HoLEP) and to assess the safety of the procedure. We retrospectively reviewed data from 202 patients who underwent HoLEP. Patients were divided into 2 groups: those with urethral stricture (group 2) and those without (group 1). Preoperative prostate-specific antigen (PSA), uroflowmetry with post-void residual (PVR), and International Prostate Symptom Score (IPSS) were evaluated. Multivariate logistic regression analysis was performed to identify independent predictors of urethral stricture. Perioperative complications were classified according to the Clavien–Dindo system. The mean age was 67.0 ± 7.6 years in group 1 and 68.4 ± 7.3 years in group 2 ( P = .335). Urethral stricture developed in 6.4% of patients. Multivariate analysis revealed that preoperative prostatitis (odds ratio [OR]: 116.81; 95% confidence interval [CI]: 1.32–10,330; P = .047) and the use of general anesthesia (OR: 269.07; 95% CI: 7.30–9912.74; P = .047) were independent predictors of stricture formation. Preoperative prostatitis and general anesthesia significantly increase the risk of urethral stricture after HoLEP.
- 17 April 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (16) , e48099
Open AccessPredictive factors for the development of urethral stricture in patients undergoing holmium laser enucleation of the prostate: A retrospective study
This study aimed to determine the incidence and predictors of urethral stricture after holmium laser enucleation of the prostate (HoLEP) and to assess the safety of the procedure. We retrospectively reviewed data from 202 patients who underwent HoLEP. Patients were divided into 2 groups: those with urethral stricture (group 2) and those without (group 1). Preoperative prostate-specific antigen (PSA), uroflowmetry with post-void residual (PVR), and International Prostate Symptom Score (IPSS) were evaluated. Multivariate logistic regression analysis was performed to identify independent predictors of urethral stricture. Perioperative complications were classified according to the Clavien–Dindo system. The mean age was 67.0 ± 7.6 years in group 1 and 68.4 ± 7.3 years in group 2 ( P = .335). Urethral stricture developed in 6.4% of patients. Multivariate analysis revealed that preoperative prostatitis (odds ratio [OR]: 116.81; 95% confidence interval [CI]: 1.32–10,330; P = .047) and the use of general anesthesia (OR: 269.07; 95% CI: 7.30–9912.74; P = .047) were independent predictors of stricture formation. Preoperative prostatitis and general anesthesia significantly increase the risk of urethral stricture after HoLEP.
- Open Access
- 31 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (44) , e45529
Does incidental prostate cancer after holmium laser enucleation of the prostate cause serious clinical problems?: Retrospective study
We aimed to investigate the predictive factors, oncologic course and functional outcomes of incidental prostate adenocarcinoma (iPCa) after holmium laser enucleation of the prostate (HoLEP). This study included 577 patients who had undergone HoLEP. Patients with a preoperative diagnosis of prostate cancer or suspected prostate cancer were excluded from the study. Patients were divided into group-1 (iPCa) and group-2 benign prostatic hyperplasia (BPH). Oncological and functional outcomes and complications at 1, 6, and 12 months were compared between the groups. To evaluate the association between clinical and demographic variables, a multivariable-adjusted logistic regression analysis was performed. In total 577 patients were included. iPCa was detected in 2.77% (16/577) of the patients who underwent HoLEP. Prostate specific antigen density had a sensitivity of 50% and specificity of 80.30% (cut-off > 0.07) for predicting iPCa (odds ratio: 0.264; 95% confidence interval: 0.099–0.430; P = .024). In the oncological follow-up of the iPCa and BPH groups, there was no statistically significant difference in prostate specific antigen level at 36 month ( P = .874). Only 1 patient was found to have Gleasen grade (3 + 4) (clinically significant) prostate cancer, since there was no progression in prostate specific antigen follow-up, no additional treatment was performed. The functional results in both the groups were similar at 36 month ( P < .05). Urethral stricture and urinary retention rates were higher in the iPCa group (4/16, 25%). The incidence of urinary infections was higher in the BPH group (1.06%; 6/561). At 36 months, and all patients were continent. The incidence of iPCa detected after HoLEP was low, and most cases were clinically insignificant.
- 31 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (44) , e45529
Open AccessDoes incidental prostate cancer after holmium laser enucleation of the prostate cause serious clinical problems?: Retrospective study
We aimed to investigate the predictive factors, oncologic course and functional outcomes of incidental prostate adenocarcinoma (iPCa) after holmium laser enucleation of the prostate (HoLEP). This study included 577 patients who had undergone HoLEP. Patients with a preoperative diagnosis of prostate cancer or suspected prostate cancer were excluded from the study. Patients were divided into group-1 (iPCa) and group-2 benign prostatic hyperplasia (BPH). Oncological and functional outcomes and complications at 1, 6, and 12 months were compared between the groups. To evaluate the association between clinical and demographic variables, a multivariable-adjusted logistic regression analysis was performed. In total 577 patients were included. iPCa was detected in 2.77% (16/577) of the patients who underwent HoLEP. Prostate specific antigen density had a sensitivity of 50% and specificity of 80.30% (cut-off > 0.07) for predicting iPCa (odds ratio: 0.264; 95% confidence interval: 0.099–0.430; P = .024). In the oncological follow-up of the iPCa and BPH groups, there was no statistically significant difference in prostate specific antigen level at 36 month ( P = .874). Only 1 patient was found to have Gleasen grade (3 + 4) (clinically significant) prostate cancer, since there was no progression in prostate specific antigen follow-up, no additional treatment was performed. The functional results in both the groups were similar at 36 month ( P < .05). Urethral stricture and urinary retention rates were higher in the iPCa group (4/16, 25%). The incidence of urinary infections was higher in the BPH group (1.06%; 6/561). At 36 months, and all patients were continent. The incidence of iPCa detected after HoLEP was low, and most cases were clinically insignificant.
- 26 September 2023
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (2) , 407-413
Efficacy of low-intensity shockwave therapy with different tadalafil regimens in patients with PDE5 inhibitor-resistant erectile dysfunction: a retrospective cohort study
Purpose Currently, there is a lack of research comparing tadalafil treatment protocols recommended during low-intensity shock wave therapy (LI-SWT) for patients with erectile dysfunction (ED) who are unresponsive to phosphodiesterase type 5 inhibitors (PDE5i). The objective of this study is to compare the efficacy of only LI-SWT versus LI-SWT plus 5 mg tadalafil daily versus LI-SWT plus 20 mg tadalafil alternate-day in PDE5i -resistant ED. Materıals and methods In this study, a cohort of 105 patients with PDE5i-resistant ED was recruited and divided into three groups labeled as A (only LI-SWT), B (LI-SWT plus 5 mg tadalafil daily), and C (LI-SWT plus 20 mg tadalafil alternate-day), comprising 27, 42, and 36 patients, respectively. The patients' International Index of Erectile Function-5 (IIEF-5) scores and the Erection Hardness Score (EHS) were evaluated at the baseline, three months and six months following the treatment. Results After three months post-treatment, the IIEF-5 scores in group A, B, and C increased by 4.1 ± 0.6, 7.3 ± 0.6, and 8.2 ± 0.6, respectively. These improvements were maintained at six months with IIEF-5 scores increasing by 3.7 ± 0.6, 7.3 ± 0.6, and 8.5 ± 0.7 in groups A, B, and C, respectively. At 3 and 6 months post-treatment, groups B and C showed significant improvement in IIEF-5 scores and EHS values compared to group A (p < 0.001). The rate of patients with EHS ≥ 3 and IIEF-5 ≥ 17 was significantly higher in groups B and C compared to group A, while there was no significantly different between groups B and C. Conclusıon In patients with PDE5i-resistant ED, PDE5i combined with LI-SWT is superior to LI-SWT monotherapy. The statistical analysis failed to demonstrate any difference between two distinct tadalafil regimens when administered with LI-SWT treatment.
- 26 September 2023
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (2) , 407-413
Efficacy of low-intensity shockwave therapy with different tadalafil regimens in patients with PDE5 inhibitor-resistant erectile dysfunction: a retrospective cohort study
Purpose Currently, there is a lack of research comparing tadalafil treatment protocols recommended during low-intensity shock wave therapy (LI-SWT) for patients with erectile dysfunction (ED) who are unresponsive to phosphodiesterase type 5 inhibitors (PDE5i). The objective of this study is to compare the efficacy of only LI-SWT versus LI-SWT plus 5 mg tadalafil daily versus LI-SWT plus 20 mg tadalafil alternate-day in PDE5i -resistant ED. Materıals and methods In this study, a cohort of 105 patients with PDE5i-resistant ED was recruited and divided into three groups labeled as A (only LI-SWT), B (LI-SWT plus 5 mg tadalafil daily), and C (LI-SWT plus 20 mg tadalafil alternate-day), comprising 27, 42, and 36 patients, respectively. The patients' International Index of Erectile Function-5 (IIEF-5) scores and the Erection Hardness Score (EHS) were evaluated at the baseline, three months and six months following the treatment. Results After three months post-treatment, the IIEF-5 scores in group A, B, and C increased by 4.1 ± 0.6, 7.3 ± 0.6, and 8.2 ± 0.6, respectively. These improvements were maintained at six months with IIEF-5 scores increasing by 3.7 ± 0.6, 7.3 ± 0.6, and 8.5 ± 0.7 in groups A, B, and C, respectively. At 3 and 6 months post-treatment, groups B and C showed significant improvement in IIEF-5 scores and EHS values compared to group A (p < 0.001). The rate of patients with EHS ≥ 3 and IIEF-5 ≥ 17 was significantly higher in groups B and C compared to group A, while there was no significantly different between groups B and C. Conclusıon In patients with PDE5i-resistant ED, PDE5i combined with LI-SWT is superior to LI-SWT monotherapy. The statistical analysis failed to demonstrate any difference between two distinct tadalafil regimens when administered with LI-SWT treatment.
- 1 August 2022
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 32 (8) , 890-895
Robot-Assisted Mini-Endoscopic Combined Intrarenal Surgery for Complex and Multiple Calculi: What Are the Real Advantages?
Background: To determine the stone-free rates (SFR) with robot-assisted mini-endoscopic combined intrarenal surgery (mini-ECIRS) and evaluate the impact of intraoperative assessment of stone-free status compared to postoperative non-contrast computed tomography (NCCT) scan findings. Methods: A total of 42 consecutive patients (44 renal units) diagnosed with complex/multiple renal stones were enrolled and reviewed in a retrospective manner. While retrograde access with the flexible scope was performed by using Avicenna Roboflex, mini-percutaneous nephrolithotomy was performed through a 16.5F sheath. Demographic, clinical characteristics of the cases along with perioperative complications were recorded, analyzed, and compared to the reported data in the literature. Results: Forty-two renal units (95.5%) were endoscopically confirmed to be stone-free at the end of the procedure, of which all were confirmed to be stone-free in postoperative NCCT examination. Complications were observed in 3 of the 42 (7.1%) patients, which were classified as Clavien grade I. The mean operation and fluoroscopy time were 103.7 ± 20.6 minutes and 71 ± 13.7 seconds, respectively. Conclusion: Our results demonstrate that robot-assisted mini-ECIRS could reveal high SFR in complex and multiple stones. In addition, endoscopic flexible ureteroscopic evaluation of the collecting system at the end of the procedure could let the surgeon predict stone-free status more reliably and successfully.
- 1 August 2022
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 32 (8) , 890-895
Robot-Assisted Mini-Endoscopic Combined Intrarenal Surgery for Complex and Multiple Calculi: What Are the Real Advantages?
Background: To determine the stone-free rates (SFR) with robot-assisted mini-endoscopic combined intrarenal surgery (mini-ECIRS) and evaluate the impact of intraoperative assessment of stone-free status compared to postoperative non-contrast computed tomography (NCCT) scan findings. Methods: A total of 42 consecutive patients (44 renal units) diagnosed with complex/multiple renal stones were enrolled and reviewed in a retrospective manner. While retrograde access with the flexible scope was performed by using Avicenna Roboflex, mini-percutaneous nephrolithotomy was performed through a 16.5F sheath. Demographic, clinical characteristics of the cases along with perioperative complications were recorded, analyzed, and compared to the reported data in the literature. Results: Forty-two renal units (95.5%) were endoscopically confirmed to be stone-free at the end of the procedure, of which all were confirmed to be stone-free in postoperative NCCT examination. Complications were observed in 3 of the 42 (7.1%) patients, which were classified as Clavien grade I. The mean operation and fluoroscopy time were 103.7 ± 20.6 minutes and 71 ± 13.7 seconds, respectively. Conclusion: Our results demonstrate that robot-assisted mini-ECIRS could reveal high SFR in complex and multiple stones. In addition, endoscopic flexible ureteroscopic evaluation of the collecting system at the end of the procedure could let the surgeon predict stone-free status more reliably and successfully.
- Open Access
- 26 November 2021
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 47 (6) , 501-508
Trends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study
Objective: The aim of this study is to show the surgical trend over the past 14 years using the data from five major centers in Turkey with accumulated experience in benign prostatic hyperplasia (BPH) surgery. Material and methods: This study included 94,954 patients with low urinary tract symptoms (LUTSs) secondary to BPH. By using electronic databases, we identified 7,163 patients who underwent BPH surgery, including monopolar transurethral prostate resection (M-TURP), bipolar transurethral prostate resection (BTURP), transurethral incision of the prostate (TUIP), open prostatectomy (OP), and holmium laser enucleation of the prostate (HoLEP) from 2006 to 2019. The years were grouped as 2006-2010, 2011-2015, and 2016-2019. Results: The total number of outpatient treatments for BPH increased by 72.9% from 5,379 in 2006 to 9,302 in 2019. Until 2019, the annual number of surgeries increased from 375 to 937 (increasing 150%). All surgical approaches for BPH, except TUIP, were most frequently performed between the ages of 60 and 69. The rate of surgery including M-TURP, B-TURP, and TUIP was statistically different between 2006 and 2010, 2011 and 2015, and 2016 and 2019 (P < .001), except OP (P ¼ .071). The highest increase was observed in HoLEP in the first half of the 2010s compared to the second half of the 2010s. The rate of M-TURP decreased from 77.9% to 17.9% from 2016 to 2019. Conclusion: With the aging population, the number of patients diagnosed and treated with BPH is increasing. B-TURP as a resection technique and HoLEP as an enucleation technique replace M-TURP. Healthcare services and government spending should be organized according to these data. Cite this article as: _Ibis MA, Cayan S, Tokatli Z, et al. Trends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study. Turk J Urol. 2021; 47(6): 501-508
- 26 November 2021
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 47 (6) , 501-508
Open AccessTrends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study
Objective: The aim of this study is to show the surgical trend over the past 14 years using the data from five major centers in Turkey with accumulated experience in benign prostatic hyperplasia (BPH) surgery. Material and methods: This study included 94,954 patients with low urinary tract symptoms (LUTSs) secondary to BPH. By using electronic databases, we identified 7,163 patients who underwent BPH surgery, including monopolar transurethral prostate resection (M-TURP), bipolar transurethral prostate resection (BTURP), transurethral incision of the prostate (TUIP), open prostatectomy (OP), and holmium laser enucleation of the prostate (HoLEP) from 2006 to 2019. The years were grouped as 2006-2010, 2011-2015, and 2016-2019. Results: The total number of outpatient treatments for BPH increased by 72.9% from 5,379 in 2006 to 9,302 in 2019. Until 2019, the annual number of surgeries increased from 375 to 937 (increasing 150%). All surgical approaches for BPH, except TUIP, were most frequently performed between the ages of 60 and 69. The rate of surgery including M-TURP, B-TURP, and TUIP was statistically different between 2006 and 2010, 2011 and 2015, and 2016 and 2019 (P < .001), except OP (P ¼ .071). The highest increase was observed in HoLEP in the first half of the 2010s compared to the second half of the 2010s. The rate of M-TURP decreased from 77.9% to 17.9% from 2016 to 2019. Conclusion: With the aging population, the number of patients diagnosed and treated with BPH is increasing. B-TURP as a resection technique and HoLEP as an enucleation technique replace M-TURP. Healthcare services and government spending should be organized according to these data. Cite this article as: _Ibis MA, Cayan S, Tokatli Z, et al. Trends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study. Turk J Urol. 2021; 47(6): 501-508
- 8 November 2021
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 14 (2) , 86-91
Does the use of a small‐size resectoscope during enucleation prevent transient urinary leakage and urethral stricture following holmium laser enucleation of the prostate?
Objective: To investigate the effect of the use of a small‐size resectoscope for enucleation during holmium laser enucleation of the prostate (HoLEP) on the prevention of transient urinary leakage (TUL) and urethral stricture (US).Methods: One hundred patients were included in a retrospective single‐center study from January 2019 to December 2020. The patients were divided into two groups according to the resectoscope size which was used for enucleation (22F in group A [n = 40] and 26F in group B [n = 60]). Patients were evaluated at 4, 12, and 24 weeks postoperatively for TUL and US. Univariate and multivariate regression analyses were implemented to assess the variables which are associated with TUL at 4 weeks.Results: Baseline characteristics and perioperative data were observed to be well balanced between groups. A statistically significant higher occurrence of TUL was detected at 4 weeks in group B compared to group A (P = .018). Higher improvement in International Prostate Symptom Score (IPSS) and quality of life (QoL) was observed in group A at 4 and 12 weeks postoperatively. On univariate analysis, resectoscope size, specimen weight, and body mass index were significant predictive factors for TUL at 4 weeks. Multivariate analysis illustrated that the resectoscope size was independently associated with TUL at 4 weeks after HoLEP (odds ratio = 3.1 [1.02‐9.38]). One patient in group A (2.5%) and two patients in group B (5%) demonstrated US (P = .648).Conclusion: Enucleation with a 22F resectoscope provides better QoL and IPSS by reducing TUL rates in the early postoperative period.
- 8 November 2021
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 14 (2) , 86-91
Does the use of a small‐size resectoscope during enucleation prevent transient urinary leakage and urethral stricture following holmium laser enucleation of the prostate?
Objective: To investigate the effect of the use of a small‐size resectoscope for enucleation during holmium laser enucleation of the prostate (HoLEP) on the prevention of transient urinary leakage (TUL) and urethral stricture (US).Methods: One hundred patients were included in a retrospective single‐center study from January 2019 to December 2020. The patients were divided into two groups according to the resectoscope size which was used for enucleation (22F in group A [n = 40] and 26F in group B [n = 60]). Patients were evaluated at 4, 12, and 24 weeks postoperatively for TUL and US. Univariate and multivariate regression analyses were implemented to assess the variables which are associated with TUL at 4 weeks.Results: Baseline characteristics and perioperative data were observed to be well balanced between groups. A statistically significant higher occurrence of TUL was detected at 4 weeks in group B compared to group A (P = .018). Higher improvement in International Prostate Symptom Score (IPSS) and quality of life (QoL) was observed in group A at 4 and 12 weeks postoperatively. On univariate analysis, resectoscope size, specimen weight, and body mass index were significant predictive factors for TUL at 4 weeks. Multivariate analysis illustrated that the resectoscope size was independently associated with TUL at 4 weeks after HoLEP (odds ratio = 3.1 [1.02‐9.38]). One patient in group A (2.5%) and two patients in group B (5%) demonstrated US (P = .648).Conclusion: Enucleation with a 22F resectoscope provides better QoL and IPSS by reducing TUL rates in the early postoperative period.
- 15 June 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (10) , e14531
Does the power of the laser devices matter for a successful HoLEP procedure? A prospective comparative study
Background The objectives of this prospective study were to evaluate the efficiency, safety and applicability of medium-power (MP) holmium laser devices in the endoscopic enucleation of the enlarged prostate (HoLEP) compared with high-power (HP) laser devices. Methods From October 2019 to July 2020, a total of 120 consecutive patients planned for HoLEP were divided randomly into two groups formed in terms of the power of the device used. While patients in group 1 were treated with a MP device (50 W) at 39.6 W (2.2 J/18 Hz), patients in group 2 were treated with HP (100 W) device at 42 W (1.2 J/35 Hz). Preoperative patient characteristics, perioperative measures and 3-month functional outcomes were evaluated in both groups with an emphasis on enucleation efficiency (EE) and haemoglobin decrease in a comparative manner. Results All patients underwent successful HoLEP surgery with no severe perioperative and postoperative complications. No statistically significant differences were observed in terms of preoperative patient characteristics and perioperative measures in the two groups. The median EE values in groups 1 and 2 were 1.15 (interquartile range [IQR]: 0.33-2.2) and 1.11 (IQR: 0.4-2.8), respectively (P = .775). Haemoglobin decrease values in groups 1 and 2 were 1.3 (IQR: 0.1-4) and 1.4 (IQR: 0.4-3.1), respectively (P = .736). There was no difference in terms of either catheterisation time or hospital stay in the groups. In the model created to predict haemoglobin decrease, only biopsy was detected to be the independent predictive factor among the data from laser device, biopsy and antithrombotic use. Functional outcomes markedly improved in all patients without any statistically significant difference between the groups in the 3-month follow-up. Conclusion Our comparative study indicated that HoLEP can be performed safely and effectively with MP laser devices without any technical difficulties and with comparable results achieved in HP laser devices.
- 15 June 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (10) , e14531
Does the power of the laser devices matter for a successful HoLEP procedure? A prospective comparative study
Background The objectives of this prospective study were to evaluate the efficiency, safety and applicability of medium-power (MP) holmium laser devices in the endoscopic enucleation of the enlarged prostate (HoLEP) compared with high-power (HP) laser devices. Methods From October 2019 to July 2020, a total of 120 consecutive patients planned for HoLEP were divided randomly into two groups formed in terms of the power of the device used. While patients in group 1 were treated with a MP device (50 W) at 39.6 W (2.2 J/18 Hz), patients in group 2 were treated with HP (100 W) device at 42 W (1.2 J/35 Hz). Preoperative patient characteristics, perioperative measures and 3-month functional outcomes were evaluated in both groups with an emphasis on enucleation efficiency (EE) and haemoglobin decrease in a comparative manner. Results All patients underwent successful HoLEP surgery with no severe perioperative and postoperative complications. No statistically significant differences were observed in terms of preoperative patient characteristics and perioperative measures in the two groups. The median EE values in groups 1 and 2 were 1.15 (interquartile range [IQR]: 0.33-2.2) and 1.11 (IQR: 0.4-2.8), respectively (P = .775). Haemoglobin decrease values in groups 1 and 2 were 1.3 (IQR: 0.1-4) and 1.4 (IQR: 0.4-3.1), respectively (P = .736). There was no difference in terms of either catheterisation time or hospital stay in the groups. In the model created to predict haemoglobin decrease, only biopsy was detected to be the independent predictive factor among the data from laser device, biopsy and antithrombotic use. Functional outcomes markedly improved in all patients without any statistically significant difference between the groups in the 3-month follow-up. Conclusion Our comparative study indicated that HoLEP can be performed safely and effectively with MP laser devices without any technical difficulties and with comparable results achieved in HP laser devices.